• Twitter
  • Jobs
ProCURE oncology
  • HOME
  • ABOUT US
  • RESEARCH GROUP
    • Molleví’s Lab
    • Antolin’s Lab
    • Alemany’s & Piulats’s lab
    • Martínez-Balibrea’s Lab
    • Aytes’s Lab
    • Belver’s Lab
    • Pujana’s Lab
    • Menendez’s Lab
    • Sureda’s & Farre’s Lab
    • Casanovas’s Lab
    • Viñals’s lab
  • INNOVATION
  • NEWS
  • CONTACT
  • Menu Menu

News

The PDGFRβ-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors

27 de November de 2013
Clin Cancer Res. 2014 Feb 1;20(3):658-67. doi: 10.1158/1078-0432.CCR-13-1131.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2013-11-27 11:00:002013-11-27 11:00:00The PDGFRβ-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors

The PDGFRβ-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors

27 de November de 2013
Clin Cancer Res. 2014 Feb 1;20(3):658-67. doi: 10.1158/1078-0432.CCR-13-1131.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2013-11-27 11:00:002013-11-27 11:00:00The PDGFRβ-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors

Epigenetic inactivation of the BRCA1 interactor SRBC and resistance to oxaliplatin in colorectal cancer

26 de November de 2013
J Natl Cancer Inst. 2014 Jan;106(1):djt322. doi: 10.1093/jnci/djt322.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2013-11-26 11:00:002013-11-26 11:00:00Epigenetic inactivation of the BRCA1 interactor SRBC and resistance to oxaliplatin in colorectal cancer

Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma

15 de October de 2013
Br J Haematol. 2014 Jan;164(1):39-52. doi: 10.1111/bjh.12582.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2013-10-15 10:00:002013-10-15 10:00:00Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma

Exploring the effect of PARP-1 flexibility in docking studies

24 de September de 2013
J Mol Graph Model. 2013 Sep;45:192-201. doi: 10.1016/j.jmgm.2013.08.006.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2013-09-24 10:00:002013-09-24 10:00:00Exploring the effect of PARP-1 flexibility in docking studies

Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis

18 de September de 2013
J Exp Med. 2013 Sep 23;210(10):1937-45. doi: 10.1084/jem.20121571.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2013-09-18 10:00:002013-09-18 10:00:00Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis

Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis

18 de September de 2013
J Exp Med. 2013 Sep 23;210(10):1937-45. doi: 10.1084/jem.20121571.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2013-09-18 10:00:002013-09-18 10:00:00Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis

A molecular signature predictive of indolent prostate cancer

13 de September de 2013
Sci Transl Med. 2013 Sep 11;5(202):202ra122. doi: 10.1126/scitranslmed.3006408.ABSTRACTMany…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2013-09-13 10:00:002013-09-13 10:00:00A molecular signature predictive of indolent prostate cancer

Analysis of cutaneous lymphomas in a medical center in Bahia, Brazil

20 de August de 2013
Am J Clin Pathol. 2013 Sep;140(3):348-54. doi: 10.1309/AJCPL52QGQPZWFHE.ABSTRACTOBJECTIVES:…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2013-08-20 10:00:002013-08-20 10:00:00Analysis of cutaneous lymphomas in a medical center in Bahia, Brazil

Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors

14 de August de 2013
BMC Cancer. 2013 Aug 10;13:382. doi: 10.1186/1471-2407-13-382.ABSTRACTBACKGROUND:…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2013-08-14 10:00:002013-08-14 10:00:00Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors

Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors

14 de August de 2013
BMC Cancer. 2013 Aug 10;13:382. doi: 10.1186/1471-2407-13-382.ABSTRACTBACKGROUND:…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2013-08-14 10:00:002013-08-14 10:00:00Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors

Clustering of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) and infective dermatitis associated with HTLV-1 (IDH) in Salvador, Bahia, Brazil

13 de August de 2013
J Clin Virol. 2013 Oct;58(2):482-5. doi: 10.1016/j.jcv.2013.07.012.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2013-08-13 10:00:002013-08-13 10:00:00Clustering of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) and infective dermatitis associated with HTLV-1 (IDH) in Salvador, Bahia, Brazil
Page 72 of 87«‹7071727374›»

Filter by categories

  • Alemany’s & Piulats’s lab (133)
  • Antolin's lab (36)
  • Aytes's Lab (25)
  • Belver's Lab (25)
  • Casanovas's Lab (77)
  • Martínez-Balibrea's Lab (43)
  • Menendez's Lab (121)
  • Molleví's Lab (35)
  • Pujana's Lab (110)
  • Sin categoría (5)
  • Sureda's & Farre's Lab (312)
  • Viñals's lab (111)

Twitter

Tweets by ProcureICO
Program Against Cancer Therapeutic Resistance

CONTACT US

Campus IDIBELL
(L’Hospitalet del Llobregat)
Hospital Duran i Reynals, Gran Via 199,
L’Hospitalet del Llobregat,
Barcelona 08908
Tel. +34 93 260 7952

Campus IGTP-IJC
(Badalona)
Campus Can Ruti – IGTP – Building Muntanya,
Rd. Can Ruti, Camí de les escoles s/n,
Badalona, Barcelona 08916
Tel. +34 93 554 3069

Campus IDIBGI
(Girona)
Parc Hospitalari Martí i Julià de Salt, Dr. Castany s/n,
Salt, Girona 17190
Tel. +34 872 987 087

© Copyright - Edisenius
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
Scroll to top
Manage cookie consent
To offer the best experiences, we use technologies such as cookies to store and/or access device information. Consent to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent, or withdrawal of consent, may adversely affect certain features and functions.
Functional Always active
Storage or technical access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. Storage or technical access that is used exclusively for anonymous statistical purposes. Without a requirement, voluntary compliance by your Internet service provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
Marketing
Storage or technical access is necessary to create user profiles to send advertising, or to track the user on a website or several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
See preferences
{title} {title} {title}